Toxicity of Resin 3-D Printing Emissions: Phase 1
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Centers for Disease Control and Prevention (CDC) intends to award a sole source firm fixed price purchase order to West Virginia University (WVU) for Phase 1 of Toxicity of Resin 3-D Printing Emissions research. This project aims to measure the toxicity associated with resin 3-D printing emissions. The government will consider responses from other interested parties received by June 13, 2026, 10am EST.
Scope of Work
The awarded vendor, WVU, will determine:
- The dose-response relationship of pulmonary inflammation and systemic toxicity induced by vat photopolymerization (VP) printing emissions in mice.
- The sensitization potential following inhalation exposure to VP printing emissions in mice.
Sole Source Justification
The CDC's intent to award to WVU is based on several critical factors:
- Expertise: Dr. Li's research at WVU aligns closely with the project's requirements, focusing on nanoparticle toxicity, immunotherapy, and advanced materials.
- Proximity: WVU's School of Medicine campus is adjacent to the NIOSH Morgantown campus, which is crucial for:
- In-person training by NIOSH staff on experimental steps.
- Transfer of a NIOSH-designed and built exposure generation system that cannot be shipped.
- Frequent coordination and technical adjustments by NIOSH staff for the specialized exposure system.
- Prompt transfer and processing of extremely sensitive biological specimens by NIOSH, preserving sample quality.
- Unique Requirements: The project requires unique training, a specific exposure system, and rapid transfer of samples with limited stability. Market research was conducted, but no other offerors were identified who could meet the combined requirements of technical expertise and close geographic proximity to NIOSH Morgantown.
Contract & Timeline
- Type: Sole Source Firm Fixed Price Purchase Order (Special Notice)
- Set-Aside: None (Sole Source Intent)
- Product Service Code: AJ11 (General Science And Technology R&D Services; General Science And Technology; Basic Research)
- Response Due: June 13, 2026, 10am EST
- Published: May 29, 2026
Action Item
This notice is not a request for competitive quotations. However, any organization believing it can fulfill the requirements should submit a quotation/response via email to Iris Gonzalez (qsx8@cdc.gov) by the deadline. Responses will be considered solely for determining whether to conduct a competitive procurement.